GW501516

DRUG2 trials

Sponsors

GlaxoSmithKline, The University of Western Australia

Conditions

Cardiovascular DiseaseDyslipidaemiasHypercholesterolemiaLipid DisordersObesity

Phase 4

Regulation of Lipoprotein Transport in Metabolic Syndrome

CompletedNCT00841217

The University of Western AustraliaCardiovascular Disease, Lipid Disorders, Obesity

Start: 2003-04-30End: 2008-12-31Updated: 2009-02-11

Unknown Phase

An Exploratory Study To Look At The Effect Of Two Investigational Drugs On Body Fat And Inflammation

CompletedNCT00388180

GlaxoSmithKlineDyslipidaemias, Hypercholesterolemia, Obesity

Start: 2004-12-31Updated: 2012-03-19